Your browser doesn't support javascript.
loading
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.
Goff, Laura W; Cohen, Roger B; Berlin, Jordan D; de Braud, Filippo G; Lyshchik, Andrej; Noberasco, Cristina; Bertolini, Francesco; Carpentieri, Marina; Stampino, Corrado Gallo; Abbattista, Antonello; Wang, Erjan; Borghaei, Hossein.
Affiliation
  • Goff LW; Vanderbilt Ingram Cancer Center, Nashville, Tennessee. laura.goff@Vanderbilt.edu.
  • Cohen RB; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Berlin JD; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
  • de Braud FG; Istituto Europeo di Oncologia, Milan, Italy.
  • Lyshchik A; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
  • Noberasco C; Istituto Europeo di Oncologia, Milan, Italy.
  • Bertolini F; Istituto Europeo di Oncologia, Milan, Italy.
  • Carpentieri M; Pfizer Oncology, Milan, Italy.
  • Stampino CG; Pfizer Oncology, Milan, Italy.
  • Abbattista A; Pfizer Oncology, Milan, Italy.
  • Wang E; Pfizer Oncology, La Jolla, California.
  • Borghaei H; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Clin Cancer Res ; 22(9): 2146-54, 2016 05 01.
Article in En | MEDLINE | ID: mdl-26655846

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activin Receptors, Type II / Antibodies, Monoclonal / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activin Receptors, Type II / Antibodies, Monoclonal / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Type: Article